Retour sur lavenir.net
   ARGENX SE 885.200 € (+0,87 %)     D'IETEREN GROUP 174.600 € (+0,81 %)     European Medical S 3.400 € (-5,56 %)     CMB.TECH 15.120 € (-1,95 %)     WDP 21.100 € (+0,76 %)     XIOR 26.750 € (+0,56 %)     UCB 217.900 € (+0,05 %)     KINEPOLIS GROUP 44.350 € (+3,74 %)     AZELIS GROUP 11.840 € (-2,15 %)     AB INBEV 66.540 € (+0,06 %)     CFE 11.650 € (-0,43 %)     NYXOAH 1.446 € (-0,28 %)     SHURGARD 23.600 € (+0,64 %)     BREDERODE 103.400 € (-1,52 %)     GBL 72.100 € (-0,83 %)     IBA 15.500 € (-1,27 %)     TITAN S.A. 50.200 € (+0,76 %)     SOFINA 240.800 € (-1,47 %)     TUBIZE-FIN 184.000 € (-0,43 %)     BARCO 7.650 € (-1,16 %)     COLRUYT 38.460 € (+0,16 %)     ONWARD MEDICAL 2.365 € (+0,21 %)     GIMV 43.800 € (-0,45 %)     ACKERMANS V.HAAREN 257.200 € (-1,00 %)     SYENSQO 79.250 € (-1,67 %)     CARE PROPERTY INV. 12.260 € (+0,99 %)     HOME INVEST BE. 18.820 € (+0,32 %)     LOTUS BAKERIES 12 660.000 € (+1,12 %)     VGP 78.800 € (-0,88 %)     EXMAR 11.300 € (-1,74 %)     VAN DE VELDE 29.500 € (-0,34 %)     AEDIFICA 68.000 € (+1,27 %)     AGFA-GEVAERT 0.400 € (-1,72 %)     BANQUP GROUP 2.030 € (-9,38 %)     CAMPINE 185.000 € (-3,39 %)     MONTEA 66.000 € (+1,07 %)     MATERIALISE 5.550 € (-3,48 %)     BPOST 1.340 € (-1,18 %)     CIE BOIS SAUVAGE 295.000 € (0,00 %)     ECONOCOM GROUP 1.480 € (+1,72 %)     AGEAS 72.150 € (-0,35 %)     BEKAERT 37.450 € (-1,06 %)     NEXTENSA 46.200 € (0,00 %)     SIPEF 101.600 € (+1,40 %)     PROXIMUS 6.180 € (-0,24 %)     KBC ANCORA 91.400 € (+0,11 %)     TINC 11.160 € (-0,36 %)     KBC 129.500 € (+0,66 %)     RETAIL ESTATES 65.300 € (+1,08 %)     ENERGYVISION 15.140 € (0,00 %)     SOLVAY 25.260 € (-2,32 %)     JENSEN-GROUP 68.400 € (-1,16 %)     QUESTFOR GR-PRICAF 2.920 € (-1,75 %)     DEME GROUP 168.600 € (-0,71 %)     VIOHALCO 17.200 € (0,00 %)     EVS 28.500 € (-1,55 %)     IMMOBEL 20.300 € (-1,93 %)     ASCENCIO 51.800 € (0,00 %)     TESSENDERLO 20.800 € (+0,48 %)     FAGRON 22.350 € (+0,22 %)  
   ING GROEP N.V. 29.740 € (-0,44 %)     CSG 18.916 € (-3,24 %)     IMCD 95.460 € (-1,63 %)     ASML HOLDING 1 505.400 € (-0,15 %)     TOTALENERGIES 78.320 € (+0,85 %)     SAFRAN 343.600 € (-1,58 %)     KALRAY 6.040 € (-2,27 %)     FORVIA 8.822 € (-1,63 %)     AEGON 7.796 € (-2,91 %)     SCOR SE 32.980 € (-1,55 %)     NEXANS 138.500 € (+0,29 %)     AKZO NOBEL 60.280 € (-0,56 %)     ESSILORLUXOTTICA 161.200 € (-1,38 %)     RELX 30.380 € (+0,93 %)     VEOLIA ENVIRON. 34.280 € (+0,62 %)     RANDSTAD NV 39.470 € (+0,30 %)     HERMES INTL 1 549.500 € (-2,09 %)     SHELL PLC 40.280 € (+0,85 %)     AIR FRANCE -KLM 11.380 € (-3,19 %)     LVMH 443.100 € (-2,83 %)     BIOPHYTIS 0.126 € (-4,55 %)     MERSEN 37.560 € (-3,59 %)     NN GROUP 75.620 € (-1,95 %)     DASSAULT SYSTEMES 22.230 € (-0,04 %)     PHILIPS KON 23.730 € (+0,59 %)     AIRBUS 204.800 € (-1,56 %)     FDJ UNITED 22.200 € (+0,36 %)     UNILEVER 54.300 € (+0,37 %)     ACOMO 23.300 € (-0,64 %)     BUREAU VERITAS 27.420 € (-0,07 %)     WOLTERS KLUWER 70.780 € (+0,23 %)     NANOBIOTIX 37.400 € (-1,89 %)     ID LOGISTICS GROUP 337.500 € (+0,45 %)     VIRBAC 330.000 € (-0,15 %)     VERALLIA 18.540 € (-1,33 %)     MERCIALYS 11.360 € (0,00 %)     LOUIS HACHETTE 1.822 € (-0,49 %)     INVENTIVA 3.955 € (-2,94 %)     METAVISIO 0.001 € (0,00 %)     ADYEN 1 062.800 € (+0,78 %)     BE SEMICONDUCTOR 210.800 € (-0,66 %)     ALTAREA 98.400 € (-0,20 %)     ASM INTERNATIONAL 824.600 € (+0,29 %)     RIBER 8.910 € (-0,45 %)     STMICROELECTRONICS 42.990 € (-2,05 %)     BNP PARIBAS ACT.A 105.960 € (-0,77 %)     KAUFMAN ET BROAD 24.850 € (-0,60 %)     SECHE ENVIRONNEM. 79.900 € (-0,25 %)     PATRIMOINE ET COMM 26.100 € (-1,88 %)     ALSTOM 15.825 € (-0,31 %)     VINCI 119.400 € (-0,79 %)     AVANTIUM 5.420 € (-3,73 %)     VALEO 14.105 € (-1,40 %)     FERRARI GROUP 7.750 € (-0,77 %)     CAPGEMINI 109.550 € (-0,72 %)     AHOLD DEL 30.940 € (-1,93 %)     SOITEC 109.750 € (+0,55 %)     INPOST 15.510 € (+0,06 %)     ACCOR 45.590 € (+0,02 %)     MAGNUM 16.990 € (+2,09 %)  
News Réglementées
25/06/2026 09:00

LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships

EQS-News: LR Health & Beauty SE / Key word(s): Bond
LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships

25.06.2026 / 09:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships

  • Successful completion of the financial realignment enables full focus on growth and further strengthening operational excellence
  • Planned investments in production and logistics will enhance efficiency, flexibility, and delivery capabilities
  • Further international growth, including expansion into new markets, targeted

Ahlen, 25 June 2026 – LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has successfully completed its financial realignment, establishing the foundation for the company’s stable and forward-looking development.

With the achievement of the final milestone, an intensive and demanding process has been successfully concluded. LR has fundamentally realigned its financing structure and significantly strengthened its capital base. An initial financing tranche of EUR 10 million was provided at the end of March, followed by a second tranche of the same amount in June.

Jörg Körfer, CEO of LR Health & Beauty SE, comments: “The past months have been challenging for many parties involved. We are therefore particularly pleased to have successfully completed the company’s financial realignment. We would like to express our sincere gratitude to our sales partners, suppliers, employees, and investors who have accompanied and supported us throughout this period. With our newly established financing structure, we now have a substantially stronger foundation for the future. Our focus is now fully directed towards further strengthening our operational capabilities, driving growth, and sustainably enhancing collaboration with our partners.”

The new financing structure has enabled the company to significantly and sustainably reduce its debt level. Lower debt service requirements create additional flexibility for targeted investments in key future areas of the company. The most important planned initiatives include:

  • Investments in production at the Ahlen site to strengthen capacity, efficiency, and flexibility, including the insourcing of a key product
  • Further development and optimization of logistics processes to enhance efficiency, delivery performance, and service quality
  • Targeted investments to support international growth, including expansion into new markets

Through these measures, LR is strengthening its position as a reliable partner throughout the entire value chain. The company also reaffirms its clear commitment to quality, delivery reliability, and sustainable growth. With the successful completion of the financial realignment, LR is opening a new chapter – built on a solid financial foundation, clear growth ambitions, and a consistent focus on the needs of its partners and customers.

 

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

 

Contact:

PR Contact:

LR Health & Beauty SE 
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.LRworld.com/

IR Contact:

cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de



25.06.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:LR Health & Beauty SE
Kruppstr. 55
59227 Ahlen
Germany
Phone:+49 238270600
E-mail:info@lrworld.com
Internet:www.lrworld.com
ISIN:NO0013149658
WKN:A3H3FM
Listed:Regulated Unofficial Market in Frankfurt; Stockholm
EQS News ID:2353198

 
End of NewsEQS News Service

2353198  25.06.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière